[Cancer immunotherapy in dermatological view (author's transl)].
The present paper summarizes clinical possibilities of postoperative cancer immunotherapy. Our therapeutic schedule in patients with malignant melanoma consists of BCG by using scarification-technique in randomized groups. Regarding the local treatment of melanoma immunotherapy with DNCB is shown to be of temporary benefit in some cases. But the current state of our knowledge on immunology of human tumours does not allow to perform an immunotherapy generally.
D001500:BCG Vaccine / Q000627:therapeutic use*; D004139:Dinitrofluorobenzene / Q000627:therapeutic use; D006801:Humans; D008545:Melanoma / Q000276:immunology / Q000628:therapy*; D012878:Skin Neoplasms / Q000276:immunology / Q000628:therapy*
D001500:BCG Vaccine; D004139:Dinitrofluorobenzene
Immuntherapie des Krebses aus der Sicht des Dermatologen.